Shane Freake is a Senior Therapeutic Development Specialist in Oncology at Gilead Sciences, where they utilize their extensive experience in the pharmaceutical industry to drive sales and enhance client engagement. Previously, they served as a Therapeutic Development Specialist in Hematology at Bristol Myers Squibb from 2019 to 2022, and prior to that, they held various roles at Bristol-Myers Squibb and Celgene, focusing on Immuno-Oncology, Oncology, and Hematology from 1999 to 2019. Shane holds a Bachelor of Science degree in Mathematics from Memorial University of Newfoundland, earned in 1985. Known for their leadership skills and innovative strategies, they have consistently achieved targeted goals and contributed to market growth throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices